发布求助
文献互助 智能选刊 最新文献

Diabetes & metabolic syndrome最新文献

筛选
英文 中文
Letter to the editor in response to the article 'Efficacy and safety of Saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis' (Dutta et al.). 致编辑的回复“Saroglitazar治疗2型糖尿病高甘油三酯血症的有效性和安全性:一项荟萃分析”(Dutta等人)。
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-10-29 DOI: 10.1016/j.dsx.2020.10.026
Ashok Jaiswal
{"title":"Letter to the editor in response to the article 'Efficacy and safety of Saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis' (Dutta et al.).","authors":"Ashok Jaiswal","doi":"10.1016/j.dsx.2020.10.026","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.10.026","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"2095"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.10.026","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38569023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection. 关注COVID-19的罕见症状:感染传播的潜在原因。
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-09-16 DOI: 10.1016/j.dsx.2020.09.017
Subodh Kumar Pathak, Sanjay Pandey, Apurva Pandey, Abhijeet Ashok Salunke, Praveen Thivari, Harish V K Ratna, Jasneet Chawla
{"title":"Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection.","authors":"Subodh Kumar Pathak,&nbsp;Sanjay Pandey,&nbsp;Apurva Pandey,&nbsp;Abhijeet Ashok Salunke,&nbsp;Praveen Thivari,&nbsp;Harish V K Ratna,&nbsp;Jasneet Chawla","doi":"10.1016/j.dsx.2020.09.017","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.09.017","url":null,"abstract":"<p><p>Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection.</p>","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1873-1874"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.09.017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38439556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Is excess weight a risk factor for the development of COVID 19 infection? A preliminary report from India. 超重是导致COVID - 19感染的危险因素吗?来自印度的初步报道。
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-09-09 DOI: 10.1016/j.dsx.2020.09.012
Piyush Ranjan, Arvind Kumar, Souradeep Chowdhury, Shivam Pandey, Aashish Choudhary, Aakashneel Bhattacharya, Amandeep Singh, Ravindra M Pandey, Naveet Wig, Naval K Vikram
{"title":"Is excess weight a risk factor for the development of COVID 19 infection? A preliminary report from India.","authors":"Piyush Ranjan,&nbsp;Arvind Kumar,&nbsp;Souradeep Chowdhury,&nbsp;Shivam Pandey,&nbsp;Aashish Choudhary,&nbsp;Aakashneel Bhattacharya,&nbsp;Amandeep Singh,&nbsp;Ravindra M Pandey,&nbsp;Naveet Wig,&nbsp;Naval K Vikram","doi":"10.1016/j.dsx.2020.09.012","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.09.012","url":null,"abstract":"<p><strong>Background and aim: </strong>This study explored the association between BMI and COVID-19 positive status in a tertiary care hospital from New Delhi.</p><p><strong>Methods: </strong>Three hundred and seventy nine adult patients who presented to COVID-19 screening outpatient department of the hospital were interviewed over the phone regarding their body weight and height. The COVID-19 RT-PCR report of the patients was extracted from the hospital information system.</p><p><strong>Results: </strong>The mean BMI and the prevalence of obesity was observed to be higher in individuals who were detected to be COVID-19 RT-PCR positive as compared to those who were negative. With every one-unit increment in BMI above 23 kg/m<sup>2</sup>, the odds of being COVID-19 positive increased by 1.8 times among these patients.</p><p><strong>Conclusion: </strong>The findings suggest a dose-response association between BMI and the odds of COVID-19 infection in individuals with excess weight.</p>","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1805-1807"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.09.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38397104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Does a younger host make the virus weaker? Presenting a new hypothesis. 年轻的宿主会使病毒变弱吗?提出一个新的假设。
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-09-13 DOI: 10.1016/j.dsx.2020.09.011
Rajeev Jayadevan, A V Raveendran
{"title":"Does a younger host make the virus weaker? Presenting a new hypothesis.","authors":"Rajeev Jayadevan,&nbsp;A V Raveendran","doi":"10.1016/j.dsx.2020.09.011","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.09.011","url":null,"abstract":"<p><strong>Background: </strong>COVID-19 is a pandemic, resulting in large number of deaths all over the world.</p><p><strong>Methods: </strong>The risk factors for mortality are not clearly understood. We are presenting a new hypothesis.</p><p><strong>Results: </strong>Virus become more virulent as it passes through weaker hosts and vice versa.</p><p><strong>Conclusions: </strong>Viruses become more virulent when it passes through weaker and older hosts. It will be worth analysing the transmission chain of COVID-19 from this perspective.</p>","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1821-1822"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.09.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38405603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The COVID-19 pandemic in developing countries: A new opportunity to improve the monitoring of patients with diabetes mellitus. COVID-19大流行在发展中国家:改善糖尿病患者监测的新机遇
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-09-22 DOI: 10.1016/j.dsx.2020.09.023
María Alejandra Quispe Flores, Marcio José Concepción Zavaleta, Esteban Alberto Plasencia Dueñas, Mikaela Kcomt Lam
{"title":"The COVID-19 pandemic in developing countries: A new opportunity to improve the monitoring of patients with diabetes mellitus.","authors":"María Alejandra Quispe Flores,&nbsp;Marcio José Concepción Zavaleta,&nbsp;Esteban Alberto Plasencia Dueñas,&nbsp;Mikaela Kcomt Lam","doi":"10.1016/j.dsx.2020.09.023","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.09.023","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1871-1872"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.09.023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38439555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on "ARIMA modelling & forecasting of COVID-19 in top five affected countries"(by Sahai et al.). 对“五大受影响国家的COVID-19的ARIMA建模和预测”的评论(Sahai等人)。
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-10-14 DOI: 10.1016/j.dsx.2020.10.006
Tadeusz Kufel, Paweł Kufel
{"title":"Comments on \"ARIMA modelling & forecasting of COVID-19 in top five affected countries\"(by Sahai et al.).","authors":"Tadeusz Kufel,&nbsp;Paweł Kufel","doi":"10.1016/j.dsx.2020.10.006","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.10.006","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1989-1990"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.10.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38514375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Can 'Fit India movement' help meeting the target of reducing physical inactivity in India? “健康印度运动”能帮助印度实现减少缺乏体育锻炼的目标吗?
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-10-07 DOI: 10.1016/j.dsx.2020.10.004
Satyajit Mohanty, Epari Venkatarao
{"title":"Can 'Fit India movement' help meeting the target of reducing physical inactivity in India?","authors":"Satyajit Mohanty,&nbsp;Epari Venkatarao","doi":"10.1016/j.dsx.2020.10.004","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.10.004","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1955-1956"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.10.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38474207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LGBTQ care at the time of COVID-19. COVID-19期间的LGBTQ护理。
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-09-07 DOI: 10.1016/j.dsx.2020.09.001
Subhankar Chatterjee, Payel Biswas, Rishi Tuhin Guria
{"title":"LGBTQ care at the time of COVID-19.","authors":"Subhankar Chatterjee,&nbsp;Payel Biswas,&nbsp;Rishi Tuhin Guria","doi":"10.1016/j.dsx.2020.09.001","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.09.001","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1757-1758"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38389955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Importance of de-escalating anti-diabetic medication to prevent hypoglycaemia. 降糖降糖对预防低血糖的重要性。
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-10-27 DOI: 10.1016/j.dsx.2020.10.024
Syed Abid, Faizah Abdulhamid
{"title":"Importance of de-escalating anti-diabetic medication to prevent hypoglycaemia.","authors":"Syed Abid,&nbsp;Faizah Abdulhamid","doi":"10.1016/j.dsx.2020.10.024","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.10.024","url":null,"abstract":"","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"2079"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.10.024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38547229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection. 他汀类药物治疗并没有改善2019冠状病毒病(COVID-19)感染的住院结果。
IF 1
Diabetes & metabolic syndrome Pub Date : 2020-11-01 Epub Date: 2020-08-26 DOI: 10.1016/j.dsx.2020.08.023
Timotius Ivan Hariyanto, Andree Kurniawan
{"title":"Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection.","authors":"Timotius Ivan Hariyanto,&nbsp;Andree Kurniawan","doi":"10.1016/j.dsx.2020.08.023","DOIUrl":"https://doi.org/10.1016/j.dsx.2020.08.023","url":null,"abstract":"<p><strong>Background and aims: </strong>The coronavirus disease 2019 (COVID-19) number of death cases is still increasing. One of the comorbidities associated with severe outcome and mortality of COVID-19 is dyslipidemia. Statin is one of the drugs which is most commonly used for the treatment of dyslipidemic patients. This study aims to analyze the association between statin use and in-hospital outcomes of COVID-19 infection.</p><p><strong>Methods: </strong>We systematically searched the Google Scholar database using specific keywords related to our aims until August 1st, 2020. All articles published on COVID-19 and statin were retrieved. Statistical analysis was done using Review Manager 5.4 software.</p><p><strong>Results: </strong>A total of 9 studies with a total of 3449 patients were included in our analysis. Our meta-analysis showed that statin use did not improve severity outcome [OR 1.64 (95% CI 0.51-5.23), p = 0.41, I<sup>2</sup> = 93%, random-effect modelling] nor mortality rate from COVID-19 infection [OR 0.78 (95% CI 0.50-1.21), p = 0.26, I<sup>2</sup> = 0%, fixed-effect modelling].</p><p><strong>Conclusion: </strong>Statin use did not improve in-hospital outcomes of COVID-19 infections. Patients with dyslipidemia should continue taking statin drugs despite COVID-19 infection status, given its beneficial effects on cardiovascular outcomes.</p>","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"1613-1615"},"PeriodicalIF":10.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2020.08.023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38342986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 76
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信